Algert Global LLC Merck & Co., Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $325,346 - $349,418	2,628 New	2,628 $325,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $51,793 - $56,363	517 Added 11.72%	4,928 $537,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $454,112 - $504,309	4,411 New	4,411 $454,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $1.59 Million - $2.04 Million	-18,218 Reduced 88.01%	2,483 $275,000
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $96,786 - $108,729	1,145 Added 5.85%	20,701 $1.78 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $1.63 Million - $1.85 Million	19,556 New	19,556 $1.78 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $312,004 - $340,095	-4,101 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $286,413 - $334,600	4,101 New	4,101 $344,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.